45 research outputs found
Lower Coquille tide gate and fish passage monitoring 2021-2022
No full textJamie Anthony (Oregon Department of Fish and Wildlife), Julie Huff (Coquille Watershed Association), Chris Claire (Oregon Department of Fish and Wildlife) ; with support from: Derrek Faber (Oregon Department of Fish and Wildlife), Morgan Davies (Oregon Department of Fish and Wildlife), Gary Vonderohe (Oregon Department of Fish and Wildlife).This archived document is maintained by the State Library of Oregon as part of the Oregon Documents Depository Program. It is for informational purposes and may not be suitable for legal purposes.Includes bibliographical references (pages 71-72).National Oceanic and Atmospheric Administration #NA20NMF4630071; Oregon Watershed Enhancement Board #218-2042-15946 220-2057-17374.Mode of access: Internet from the Oregon Government Publications Collection.Text in English
Low Budget Energy for the Third World
No full textA prototype powered by water runoffFall 2012Accompanied by video fil
Blossoming Virtually: Elevating Village Florist's Digital Presence
No full text[ABSTRACT ONLY; NO FULL TEXT] This report details a consulting project for Village Florist, a floral arrangement business in Granada Hills, Los Angeles. Aimed at boosting their digital presence and operational efficiency, the team utilized data from Village Florist, such as tax returns and supplier agreements, and secondary sources like IBISWorld and the US Census Bureau. This research, coupled with industry stakeholder interviews, website analysis, and targeted surveys, informed a comprehensive market positioning assessment for Village Florist. The findings reveal a mature, oversaturated floral industry, emphasizing the importance of an enhanced digital presence for Village Florist to maintain industry relevance. The primary responsibility of the report's author included conducting an external industry analysis using Porter's Five Forces, identifying SWOT analysis opportunities and threats, and leading primary research on the client's e-commerce presence. I contributed 10-15 hours weekly, focusing on research, writing, and analysis, and presented the findings and recommendations to the client
Predictors of Futile Recanalization After Endovascular Therapy for Acute Large Vessel Occlusive Intracranial Atherosclerosis: A Secondary Analysis of RESCUE-ICAS
No full textBACKGROUND AND OBJECTIVES: Futile recanalization in endovascular thrombectomy (EVT) occurs when recanalization is achieved but patients nevertheless experience a poor functional outcome. Variables associated with futile recanalization after endovascular therapy in intracranial atherosclerosis-related large vessel occlusion have not been previously described. METHODS: This was a secondary analysis of Registry of Emergent Large Vessel Occlusion due to Intracranial Stenosis (RESCUE-ICAS), a multicenter prospective observational cohort study conducted at 25 EVT-capable centers in North America, Europe, and Asia. RESCUE-ICAS enrolled patients who underwent EVT, after which they had residual stenosis of 50% to 99% or intraprocedural reocclusion. This particular analysis focused on patients who had “futile recanalization” after endovascular therapy, that is modified Rankin Score 3 to 6 at 90-day follow-up despite successful revascularization at procedure end (modified thrombolysis in cerebral ischemia [mTICI] 2b-3). All Included patients in the study had baseline modified Rankin Scale 0 to 2, occlusion of the intracranial internal carotid artery or M1 segment, and successful recanalization (mTICI 2b-3) after endovascular therapy. RESULTS: In total, 325 patients (62.8% male, mean age: 66.2 years) met the inclusion criteria. On multivariable logistic regression analysis, several variables were independently associated with futile recanalization and poor outcome, including relatively old age, higher National Institutes of Health Stroke Scale, history of type 2 diabetes, and total number of revascularization attempts. On the other hand, complete angiographic recanalization (mTICI 3 vs mTICI 2b/c) and use of an intracranial stent were inversely associated with poor outcome and were independently protective against futile recanalization. CONCLUSION: Recanalization outcomes in intracranial atherosclerosis-related large vessel occlusion are inferior to thromboembolic large vessel occlusion. The broader RESCUE-ICAS cohort showed that stenting may augment end EVT thrombolysis in cerebral ischemia grading. In this analysis, which was restricted to patients experiencing good recanalization, stenting remained inversely associated with futile recanalization. Follow-up vessel imaging suggests this may be due to more durable vessel patency with stenting
Empty Cyst Sign Appearance of CSF-Venous Fistula on Digital Spinal Myelography.
No full textCerebrospinal fluid venous fistulas (CSF-VFs) are an uncommon, yet increasingly recognized, cause of spontaneous intracranial hypotension
Prevalence of SLEC-negative spontaneous intracranial hypotension in patients with spinal nerve root sleeve diverticula on MRI.
No full textPURPOSE: While there is thought to be an association between spinal nerve root diverticula (NRD) and spontaneous intracranial hypotension (SIH) without a spinal longitudinal epidural collection (SLEC), it remains unclear what the overall prevalence of SLEC-negative SIH is in patients with NRD on MRI.
METHODS: Spine MRI imaging reports from our single institution were electronically screened for instances of NRD over a 9-year period (2016-2023). From these cases, patients with brain MRIs consistent with SIH were also identified. Subsequently, the overall proportion of SLEC-negative SIH was determined as a function of total cases with NRD based on spinal level.
RESULTS: In total, 83,843 patients with spinal MRIs were screened which identified 4174 (4.97%) with NRD. From these, there were 1203 cervical, 622 thoracic, and 2979 lumbosacral spine MRIs. In total, 16 patients (0.38%; Standard Error [SE]: 0.48%-0.28%) had a brain MRI compatible with SLEC-negative SIH and met ICHD-3 criteria. Patients with cervical NRD had SIH in 2 cases (0.16%; SE: 0.27%-0.05%). SLEC-negative SIH was present in 11 patients with lumbosacral NRD (0.34%; SE: 0.44%-0.24%). In patients with diverticula in the thoracic spine, 14 (2.3%; SE: 2.8%-1.8%) had SLEC-negative SIH. SLEC-negative SIH was significantly more prevalent in patients with thoracic diverticula compared to those with cervical (
CONCLUSION: In patients with spinal NRD, concurrent SLEC-negative SIH is present in approximately 0.38% of patients, suggesting that in the vast majority of cases, they are an incidental finding. However, SIH is present in approximately 2.3% of patients with thoracic NRD and may be more specific for leak localization
Cervicothoracic epidural hematoma in a toddler with miosis, ptosis, nonspecific symptoms, and no history of major trauma: case report
No full textEuropean Research on Electrochemotherapy in Head and Neck Cancer (EURECA) project: Results of the treatment of skin cancer
No full textAbstractElectrochemotherapy is an effective and safe method for local treatment of cutaneous and subcutaneous tumours, where electric pulses cause increased permeability of cell membranes in the tumour mass, enabling dramatically enhanced effectiveness of bleomycin and other hydrophilic drugs. Here, we report results of a European multi-institutional prospective study of the effectiveness of electrochemotherapy in the treatment of skin cancer of the head and neck (HN) area, where standard treatments had either failed or were not deemed suitable or declined by the patient. A total of 105 patients affected by primary or recurrent skin cancer of the HN area were enrolled; of these, 99 were eligible for evaluation of tumour response. By far, the majority (82%) were treated only once, and 18% of patients had a second treatment. The objective response was highest for basal cell carcinoma (97%) and for other histologies was 74%. Small, primary, and treatment-naive carcinomas responded significantly better (p < 0.05), as investigated by univariate analysis. Electrochemotherapy was well tolerated and led to a significant improvement of quality of life, estimated by the European Organisation for Research and Treatment of Cancer quality of life questionnaires. At 1-year follow-up, the percentages of overall and disease-free survival were 76% and 89%, respectively. Electrochemotherapy is an effective option for skin cancers of the HN area and can be considered a feasible alternative to standard treatments when such an alternative is appropriate. The precise role for electrochemotherapy in the treatment algorithm for non-melanoma skin cancer of the HN region requires data from future randomised controlled studies.(ISRCTN registry N. 30427
Endovascular therapy versus medical management for ischemic stroke presenting beyond 24 hours: Systematic review and meta-analysis.
No full textOBJECTIVE: The ideal management for ischemic stroke presenting in the very late time window, or beyond 24 hours from onset, is poorly understood. It is unknown if endovascular therapy (EVT) or best medical management (MM) is associated with superior clinical outcomes.
METHODS: A systematic literature and comparative meta-analysis was completed to evaluate the safety and efficacy of EVT vs. MM for stroke presenting beyond 24 hours. Outcome measures included: 90 day functional independence (mRS 0-2), 90 day mortality, and symptomatic intracranial hemorrhage (sICH) occurrence. A random effects model was used for quantitative synthesis.
RESULTS: From the five included studies, a total of 704 patients were included with 461 treated with EVT and 243 treated with MM alone. The proportion of patients achieving functional independence was significantly higher in patients treated with EVT (34.6 %) compared to MM alone (15.9 %) (OR: 4.24; CI: 2.61-6.88, P \u3c 0.00001; I
CONCLUSIONS: In certain patients presenting beyond 24 hours with ischemic stroke, EVT is associated with a significantly higher odds of achieving functional independence and lower odds of mortality compared with MM. While these results do not function as proof, they do encourage further research into extending the window beyond 24 hours for EVT. Randomized clinical trials are warranted to validate these findings
